Cargando…

Unveiling the G4-PAMAM capacity to bind and protect Ang-(1-7) bioactive peptide by molecular dynamics simulations

Angiotensin-(1-7) re-balance the Renin-Angiotensin system affected during several pathologies, including the new COVID-19; cardiovascular diseases; and cancer. However, one of the limiting factors for its therapeutic use is its short half-life, which might be overcome with the use of dendrimers as n...

Descripción completa

Detalles Bibliográficos
Autores principales: Chi, L. América, Asgharpour, Somayeh, Correa-Basurto, José, Bandala, Cindy Rodríguez, Martínez-Archundia, Marlet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358120/
https://www.ncbi.nlm.nih.gov/pubmed/35934747
http://dx.doi.org/10.1007/s10822-022-00470-5
_version_ 1784763864365137920
author Chi, L. América
Asgharpour, Somayeh
Correa-Basurto, José
Bandala, Cindy Rodríguez
Martínez-Archundia, Marlet
author_facet Chi, L. América
Asgharpour, Somayeh
Correa-Basurto, José
Bandala, Cindy Rodríguez
Martínez-Archundia, Marlet
author_sort Chi, L. América
collection PubMed
description Angiotensin-(1-7) re-balance the Renin-Angiotensin system affected during several pathologies, including the new COVID-19; cardiovascular diseases; and cancer. However, one of the limiting factors for its therapeutic use is its short half-life, which might be overcome with the use of dendrimers as nanoprotectors. In this work, we addressed the following issues: (1) the capacity of our computational protocol to reproduce the experimental structural features of the (hydroxyl/amino)-terminated PAMAM dendrimers as well as the Angiotensin-(1-7) peptide; (2) the coupling of Angiotensin-(1-7) to (hydroxyl/amino)-terminated PAMAM dendrimers in order to gain insight into the structural basis of its molecular binding; (3) the capacity of the dendrimers to protect Angiotensin-(1-7); and (4) the effect of pH changes on the peptide binding and covering. Our Molecular-Dynamics/Metadynamics-based computational protocol well modeled the structural experimental features reported in the literature and our double-docking approach was able to provide reasonable initial structures for stable complexes. At neutral pH, PAMAM dendrimers with both terminal types were able to interact stably with 3 Angiotensin-(1-7) peptides through ASP1, TYR4 and PRO7 key amino acids. In general, they bind on the surface in the case of the hydroxyl-terminated compact dendrimer and in the internal zone in the case of the amino-terminated open dendrimer. At acidic pH, PAMAM dendrimers with both terminal groups are still able to interact with peptides either internalized or in its periphery, however, the number of contacts, the percentage of coverage and the number of hydrogen bonds are lesser than at neutral pH, suggesting a state for peptide release. In summary, amino-terminated PAMAM dendrimer showed slightly better features to bind, load and protect Angiotensin-(1-7) peptides. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10822-022-00470-5.
format Online
Article
Text
id pubmed-9358120
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-93581202022-08-09 Unveiling the G4-PAMAM capacity to bind and protect Ang-(1-7) bioactive peptide by molecular dynamics simulations Chi, L. América Asgharpour, Somayeh Correa-Basurto, José Bandala, Cindy Rodríguez Martínez-Archundia, Marlet J Comput Aided Mol Des Article Angiotensin-(1-7) re-balance the Renin-Angiotensin system affected during several pathologies, including the new COVID-19; cardiovascular diseases; and cancer. However, one of the limiting factors for its therapeutic use is its short half-life, which might be overcome with the use of dendrimers as nanoprotectors. In this work, we addressed the following issues: (1) the capacity of our computational protocol to reproduce the experimental structural features of the (hydroxyl/amino)-terminated PAMAM dendrimers as well as the Angiotensin-(1-7) peptide; (2) the coupling of Angiotensin-(1-7) to (hydroxyl/amino)-terminated PAMAM dendrimers in order to gain insight into the structural basis of its molecular binding; (3) the capacity of the dendrimers to protect Angiotensin-(1-7); and (4) the effect of pH changes on the peptide binding and covering. Our Molecular-Dynamics/Metadynamics-based computational protocol well modeled the structural experimental features reported in the literature and our double-docking approach was able to provide reasonable initial structures for stable complexes. At neutral pH, PAMAM dendrimers with both terminal types were able to interact stably with 3 Angiotensin-(1-7) peptides through ASP1, TYR4 and PRO7 key amino acids. In general, they bind on the surface in the case of the hydroxyl-terminated compact dendrimer and in the internal zone in the case of the amino-terminated open dendrimer. At acidic pH, PAMAM dendrimers with both terminal groups are still able to interact with peptides either internalized or in its periphery, however, the number of contacts, the percentage of coverage and the number of hydrogen bonds are lesser than at neutral pH, suggesting a state for peptide release. In summary, amino-terminated PAMAM dendrimer showed slightly better features to bind, load and protect Angiotensin-(1-7) peptides. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10822-022-00470-5. Springer International Publishing 2022-08-08 2022 /pmc/articles/PMC9358120/ /pubmed/35934747 http://dx.doi.org/10.1007/s10822-022-00470-5 Text en © The Author(s), under exclusive licence to Springer Nature Switzerland AG 2022, Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
Chi, L. América
Asgharpour, Somayeh
Correa-Basurto, José
Bandala, Cindy Rodríguez
Martínez-Archundia, Marlet
Unveiling the G4-PAMAM capacity to bind and protect Ang-(1-7) bioactive peptide by molecular dynamics simulations
title Unveiling the G4-PAMAM capacity to bind and protect Ang-(1-7) bioactive peptide by molecular dynamics simulations
title_full Unveiling the G4-PAMAM capacity to bind and protect Ang-(1-7) bioactive peptide by molecular dynamics simulations
title_fullStr Unveiling the G4-PAMAM capacity to bind and protect Ang-(1-7) bioactive peptide by molecular dynamics simulations
title_full_unstemmed Unveiling the G4-PAMAM capacity to bind and protect Ang-(1-7) bioactive peptide by molecular dynamics simulations
title_short Unveiling the G4-PAMAM capacity to bind and protect Ang-(1-7) bioactive peptide by molecular dynamics simulations
title_sort unveiling the g4-pamam capacity to bind and protect ang-(1-7) bioactive peptide by molecular dynamics simulations
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358120/
https://www.ncbi.nlm.nih.gov/pubmed/35934747
http://dx.doi.org/10.1007/s10822-022-00470-5
work_keys_str_mv AT chilamerica unveilingtheg4pamamcapacitytobindandprotectang17bioactivepeptidebymoleculardynamicssimulations
AT asgharpoursomayeh unveilingtheg4pamamcapacitytobindandprotectang17bioactivepeptidebymoleculardynamicssimulations
AT correabasurtojose unveilingtheg4pamamcapacitytobindandprotectang17bioactivepeptidebymoleculardynamicssimulations
AT bandalacindyrodriguez unveilingtheg4pamamcapacitytobindandprotectang17bioactivepeptidebymoleculardynamicssimulations
AT martinezarchundiamarlet unveilingtheg4pamamcapacitytobindandprotectang17bioactivepeptidebymoleculardynamicssimulations